This Personalized Crispr Therapy Is Designed to Attack Tumors
by Emily Mullin from on (#65P94)
In a small study, researchers modified patients' immune cells to target their particular cancer-but it only worked for a third of volunteers.In a small study, researchers modified patients' immune cells to target their particular cancer-but it only worked for a third of volunteers.